Not sure which company would be more potentially profitable to go with? They have an upcoming PDUFA with a target action date of Feb 14, 2018. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) is developing a drug called "Makena® subcutaneous auto-injector" which reduces the risk of preterm birth in...